What is Small Dense LDL (sdLDL)?
sdLDL particles are more likely to:
• Penetrate the arterial wall
• Undergo oxidation
• Remain in circulation longer
These properties make sdLDL significantly more associated with plaque formation and cardiovascular disease risk compared to larger LDL particles. Elevated sdLDL is commonly seen in insulin resistance, metabolic syndrome, and chronic inflammation.
Why Test for sdLDL?
Evaluating sdLDL provides deeper insight into cardiovascular and metabolic risk beyond traditional lipid panels. It is commonly used to assess:
Clinical Significance of sdLDL Levels
- High sdLDL Levels: sdLDL levels above ~30–40 mg/dL are generally considered elevated
(method-dependent) and are strongly associated with increased cardiovascular risk due to their
enhanced ability to infiltrate arterial walls and undergo oxidation. High levels are commonly seen in
insulin resistance and type 2 diabetes, elevated triglycerides with low HDL, obesity and visceral
adiposity, as well as chronic inflammation. Clinically, this pattern is often linked to accelerated
atherosclerosis, endothelial dysfunction, and increased risk of coronary artery disease—even when
LDL-C appears within range. - High sdLDL Levels: sdLDL levels below ~20–30 mg/dL are generally considered favorable and reflect a predominance of larger, less atherogenic LDL particles. This pattern is often associated with good
metabolic health, balanced lipid metabolism, and lower overall cardiovascular risk.
Actionable Insights
triglycerides, HDL, ApoB, and markers of insulin resistance. Elevated sdLDL often reflects an
underlying metabolic pattern—frequently associated with insulin resistance, elevated triglycerides, low
HDL, visceral adiposity, and chronic inflammation—rather than a primary lipid disorder. This pattern
contributes to a more atherogenic environment, with increased susceptibility to lipoprotein oxidation,
endothelial dysfunction, and plaque development, even when LDL-C appears within range. In many
cases, addressing insulin resistance, dietary patterns (particularly refined carbohydrates),
inflammation, and body composition can significantly reduce sdLDL levels. Conversely, lower sdLDL
levels tend to reflect more favorable lipid distribution and metabolic balance. Monitoring trends over
time helps assess whether interventions are improving lipoprotein quality, not just cholesterol levels.
Optimal Ranges
• <20–30 mg/dL
Note: Reference ranges vary by laboratory. In functional medicine, some providers may consider a narrower interpretive window to help guide clinical context. These values are not standardized and should be interpreted in conjunction with the ordering provider’s judgment.
“Routinely considering sdLDL (or its surrogates like TG/HDL ratio) alongside ApoB, can shift management from cholesterol-lowering alone, to targeting insulin sensitivity, which more effectively improves lipoprotein quality and may reduce plaque progression where standard therapy falls short.”
Dr. Mitch Ghen - Director of Physician Consultations, Access Labs
Disclaimer: Content on the Access Labs blog is for informational purposes only and reflects the views of individual contributors, not necessarily those of Access Labs. We do not endorse specific treatments, products, or protocols. This content is not a substitute for professional medical advice. Always consult a qualified healthcare provider regarding any medical concerns.
About Access:
Access is the nation’s premier specialty diagnostic lab. We offer a broad menu of testing from blood, saliva, urine & swab samples. We perform all of your tests in our 25,000 sq. ft. ultra-automated facility in Jupiter, Florida & provide results within 24hrs. Since 2003, we continuously strive to innovate, inspire, and improve solutions for physicians by providing an exceptional personalized experience with the most accurate testing.
Feel free to contact our specialist to find out more about prices and services. We are always ready to answer your questions: sales@accessmedlab.com
Share:
Lab Overview: Cortisol
.jpg)
Lab Overview: Epstein-Barr Virus (EBV)
